The Competition Bureau Canada announced Friday it has obtained a court order to advance investigation into NuvoCare’s weight loss claims.
In a statement issued earlier today, the Competition Bureau said it has obtained a court order to advance an ongoing investigation into weight loss claims made by NuvoCare Health Sciences Inc. about certain natural health products.
The statement further added that those products include WeightOFF Max!, Forskolin+ and Forskolin Nx.
The order granted by the Federal Court of Canada on January 5, 2022 requires NuvoCare to produce records and information relevant to the Bureau’s investigation.
The Bureau is investigating the marketing practices of NuvoCare under the deceptive marketing practices provisions of the Competition Act.
In May 2020, the Bureau and NuvoCare entered into a temporary consent agreement that prohibits the company from making certain weight loss related claims while the Bureau completes its investigation.
The Competition Bureau also added that the agreement remains in effect until the Bureau’s investigation is resolved.